Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for the Detection of Cardiotoxicity Under Anthracycline-containing Cancer Therapy

NCT07528586 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Cardiotoxicity
Anthracycline-induced Cardiotoxicity

Interventions

DIAGNOSTIC_TEST: CMR based measurement of cardiotoxicity
OTHER: biosampling for scientific research in study-specific biobank

Sponsor

Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)